InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-11.6%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by McCracken Joseph S, Director. Officer active across 4 companies, notably LUMOS PHARMA, INC.. In total, 11 filings have been logged. Split: 5 buys · 0 sell. Total volume traded: €199k. History available since 20 May 2021. The latest transaction was disclosed on 12 December 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations11 total
40,000 shares0Common StockSEC:0000950170-24-136770:0
15,721 sharesCommon StockSEC:0001126234-24-000111:0
20,000 shares@ US$2.9536100.0% of flowCommon StockSEC:0000950170-24-129007:0
Ideal exit: 16 Aug 2025 (T+270)
22,500 shares0Common StockSEC:0001209191-23-058841:0
4,000 shares@ US$5.0320.5% of flowCommon StockSEC:0001126234-22-000114:0
Ideal exit: 13 Aug 2023 (T+270)
3,170 shares@ US$8.6028.8% of flowCommon StockSEC:0001126234-22-000092:0
Ideal exit: 22 May 2023 (T+270)
7,475 shares@ US$7.546100.0% of flowCommon StockSEC:0001126234-21-000112:0
Ideal exit: 8 May 2022 (T+270)
7,475 shares@ US$7.546100.0% of flowCommon StockSEC:0001126234-21-000112
Ideal exit: 8 May 2022 (T+270)
367 shares0Common StockSEC:0001126234-21-000081
367 shares0Common StockSEC:0001126234-21-000081:0
500 sharesOrdinary SharesSEC:0001572426-16-000152:0
11 of 11 declarations
About McCracken Joseph S
Joseph S. McCracken is a Board Member at LUMOS PHARMA, INC. He is involved in overseeing the company's activities and in strategic decision-making. His role on the board allows him to provide valuable insights into governance and performance issues. Joseph helps ensure that decisions made are aligned with LUMOS's strategic objectives.
